Eye & Ent Hospital Of Fudan University

This study tests a combination of the immunotherapy drug tislelizumab, chemotherapy, and radiation for people with early-stage (I-II) NK/T-cell lymphoma, a rare blood cancer. The goal is to see if this approach improves how many patients respond and helps prevent the cancer from …

This study is testing a treatment plan for adults with a rare type of sinus cancer called rhabdomyosarcoma. The plan includes chemotherapy, radiation therapy, and surgery. The goal is to see if this approach can shrink tumors and help people live longer. About 43 people will take…